2-Amino-5-aryl-pyridines as selective CB2 agonists: Synthesis and investigation of structure-activity relationships

被引：11

作者：

Gleave, Robert J. ^{[1
]}

Beswick, Paul J. ^{[1
]}

Brown, Andrew J. ^{[1
]}

Giblin, Gerard M. P. ^{[1
]}

Haslam, Carl P. ^{[1
]}

Livermore, David ^{[1
]}

Moses, Andrew ^{[1
]}

Nicholson, Neville H. ^{[1
]}

Page, Lee W. ^{[1
]}

Slingsby, Brian ^{[1
]}

Swarbrick, Martin E. ^{[1
]}

机构：

[1] GlaxoSmithKline, Neurosci Ctr Excellence Drug Discovery, Pain & Neuroexcitabil Discovery Performance Unit, Harlow CM19 5AW, Essex, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 23期

关键词：

Cannabinoid; CB2; CB1; SAR; CANNABINOID RECEPTOR; PHARMACOLOGY;

D O I：

10.1016/j.bmcl.2009.10.041

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

2-Amino-5-aryl-pyridines, exemplified by compound 1, had been identified as a synthetically tractable series of CB2 agonists from a high-throughput screen of the GlaxoSmithKline compound collection. Described herein are the results of an investigation of the structure-activity relationships (SAR) which led to the identification a number of potent and selective agonists. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：6578 / 6581

页数：4

共 50 条

[41] Discovery and optimization of novel purines as potent and selective CB2 agonists
Hollinshead, Sean P.
Astles, Peter C.
Mark, Chambers C.
Johnson, Michael P.
Tidwell, Michael W.
Palmer, John
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[42] Novel series of CB2 selective agonists for the treatment of neuropathic pain
Petrov, Ravil R.
Astruc-Diaz, Fanny
Cavasotto, Claudio N.
Diaz, Philippe
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
[43] Structure-Activity Relationships of 2-Benzylsulfanylbenzothiazoles: Synthesis and Selective Antimycobacterial Properties
Klimesova, Vera
Koci, Jan
Palat, Karel
Stolarikova, Jirina
Dahse, Hans-Martin
Moellmann, Ute
MEDICINAL CHEMISTRY, 2012, 8 (02) : 281 - 292
[44] Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective Agonists
Ashton, John C.
Wright, Jason L.
McPartland, John M.
Tyndall, Joel D. A.
CURRENT MEDICINAL CHEMISTRY, 2008, 15 (14) : 1428 - 1443
[45] Design, synthesis, and binding mode prediction of 2-pyridone-based selective CB2 receptor agonists
Kusakabe, Ken-ichi
Tada, Yukio
Iso, Yasuyoshi
Sakagami, Masahiro
Morioka, Yasuhide
Chomei, Nobuo
Shinonome, Satomi
Kawamoto, Keiko
Takenaka, Hideyuki
Yasui, Kiyoshi
Hamana, Hiroshi
Hanasaki, Kohji
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (07) : 2045 - 2055
[46] Design and synthesis of selective CB2 receptor antagonists
Xiang, JN
Atkinson, ST
Wang, DY
Lee, J
Lee, JC
Chritensen, SB
Elliott, JD
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U203 - U204
[47] Synthesis and structure-activity relationships for anticipated molluscicidal activity of some 2-amino-5-substituted pyridine derivatives
El-Zemity, SR
Radwan, MA
PESTICIDE SCIENCE, 1999, 55 (12): : 1203 - 1209
[48] Resorcinol derivatives:: A novel template for the development of cannabinoid CB1/CB2 and CB2-selective agonists
Wiley, JL
Beletskaya, ID
Ng, EW
Dai, ZM
Crocker, PJ
Mahadevan, A
Razdan, RK
Martin, BR
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (02): : 679 - 689
[49] Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships
Mendoza, Adela
Perez-Silanes, Silvia
Quiliano, Miguel
Pabon, Adriana
Galiano, Silvia
Gonzalez, German
Garavito, Giovanny
Zimic, Mirko
Vaisberg, Abraham
Aldana, Ignacio
Monge, Antonio
Deharo, Eric
EXPERIMENTAL PARASITOLOGY, 2011, 128 (02) : 97 - 103
[50] Synthesis and structure-activity relationships of a series of 3-aryl-4-isoxazolecarboxamides as a new class of TGR5 agonists
Budzik, Brian W.
Evans, Karen A.
Wisnoski, David D.
Jin, Jian
Rivero, Ralph A.
Szewczyk, George R.
Jayawickreme, Channa
Moncol, David L.
Yu, Hongshi
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (04) : 1363 - 1367

← 1 2 3 4 5 →